Table Of Contents

1. Introduction 23
1.1. Objectives Of The Study 23
1.2. Market Definition 23
1.3. Overview Of Global Anti-Nuclear Antibody Test Market 24
1.4. Currency And Pricing 24
1.5. Limitation 24
1.6. Markets Covered 25
2. Market Segmentation 27
2.1. Markets Covered 27
2.2. Geographic Scope 28
2.3. Years Considered For The Study 29
2.4. Currency And Pricing 29
2.5. Research Methodology 30
2.6. Primary Interviews With Key Opinion Leaders 33
2.7. Secondary Sources 34
2.8. Assumptions 34
3. Market Overview 35
3.1. Drivers 37
3.1.1. Increasing Incidence Of Autoimmune Diseases 37
3.1.2. Rising Medical Insurance 38
3.1.3. Rise In Government Healthcare Protection 39
3.2. Restraints 40
3.2.1. Strict Regulation For Product Approval 40
3.3. Opportunities 41
3.3.1. Increasing Growth In Healthcare Expenditure 41
3.3.2. Emerging Markets 43
3.3.3. Laboratory Automation Favors The Market 43
3.4. Challenges 44
3.4.1. Lack Of Skilled Professionals 44
4. Executive Summary 45
5. Premium Insights 48
6. Global Anti-Nuclear Antibody Test Market, By Product 55
6.1. Overview 56
6.2. Assay Kits & Reagents 58
6.3. Systems 59
6.4. Software 60
7. Global Anti-Nuclear Antibody Test Market, By Test 61
7.1. Overview 62
7.2. Indirect Immunofluorescence 64
7.3. Elisa 65
7.4. Multiplex Testing 66
8. Global Anti-Nuclear Antibody Test Market, By Disease 67
8.1. Overview 68
8.2. Rheumatoid Arthritis 70
8.3. Systemic Lupus Erythematosus 71
8.4. Sj?gren?S Syndrome 72
8.5. Scleroderma 73
8.6. Polymyositis 74
8.7. Others 75
9. Global Anti-Nuclear Antibody Test Market, By End User 76
9.1. Overview 77
9.2. Hospitals 79
9.3. Clinics 80
9.4. Physician Office Laboratories 81
9.5. Others 82
10. Global Anti-Nuclear Antibody Test Market, By Geography 83
10.1. Overview 84
10.2. North America 91
10.2.1. U.S. 101
10.2.2. Canada 104
10.2.3. Mexico 107
10.3. Europe 110
10.3.1. Germany 120
10.3.2. France 123
10.3.3. U.K. 126
10.3.4. Italy 129
10.3.5. Spain 132
10.3.6. Switzerland 135
10.3.7. Netherlands 138
10.3.8. Belgium 141
10.3.9. Russia 144
10.3.10. Turkey 147
10.3.11. Rest Of Europe 150
10.4. Asia-Pacific 151
10.4.1. China 161
10.4.2. Japan 164
10.4.3. India 167
10.4.4. South Korea 170
10.4.5. Australia 173
10.4.6. Singapore 176
10.4.7. Thailand 179
10.4.8. Malaysia 182
10.4.9. Indonesia 185
10.4.10. Philippines 188
10.4.11. Rest Of Asia-Pacific 191
10.5. South America 192
10.5.1. Brazil 202
10.5.2. Rest Of South America 205
10.6. Middle East & Africa 206
10.6.1. South Africa 216
10.6.2. Rest Of Middle East & Africa 219
11. Global Anti-Nuclear Antibody Test Market,
Company Landscape 220
11.1. Company Share Analysis; Global 220
11.2. Company Share Analysis; North America 221
11.3. Company Share Analysis; Europe 222
11.4. Company Share Analysis; Asia Pacific 223
12. Company Profiles 224
12.1. Thermo Fisher Scientific Inc. 224
12.1.1. Company Overview 224
12.1.2. Thermo Fisher Scientific Inc.;Revenue Analysis 224
12.1.3. Product Portfolio 225
12.1.4. Recent Developments 225
12.2. Merck Kgaa 226
12.2.1. Company Overview 226
12.2.2. Merck Kgaa; Revenue Analysis 226
12.2.3. Product Portfolio 227
12.2.4. Recent Developments 227
12.3. Alere Inc. 228
12.3.1. Company Overview 228
12.3.2. Alere Inc.; Revenue Analysis 228
12.3.3. Product Portfolio 229
12.3.4. Recent Developments 229
12.4. Trinity Biotech 230
12.4.1. Company Overview 230
12.4.2. Trinity Biotech; Company Overview 230
12.4.3. Product Portfolio 231
12.4.4. Recent Developments 231
12.5. Antibodies Inc. 232
12.5.1. Company Overview 232
12.5.2. Antibodies Inc.; Revenue Analysis 232
12.5.3. Product Portfolio 232
12.5.4. Recent Developments 232
12.6. Bio-Rad Laboratories, Inc. 233
12.6.1. Company Overview 233
12.6.2. Bio-Rad Laboratories, Inc.; Company Snapshot 233
12.6.3. Product Portfolio 234
12.6.4. Recent Developments 234
12.7. Euroimmun Ag (A Subsidiary Of Perkinelmer Inc.) 235
12.7.1. Company Overview 235
12.7.2. Perkinelmer Inc.; Revenue Analysis 235
12.7.3. Product Portfolio 236
12.7.4. Recent Developments 236
12.8. Immuno Concepts 237
12.8.1. Company Overview 237
12.8.2. Immuno Concepts; Company Snapshot 237
12.8.3. Product Portfolio 238
12.8.4. Recent Developments 238
?
12.9. Inova Diagnostics 239
12.9.1. Company Overview 239
12.9.2. Inova Diagnostics;Company Snapshot 239
12.9.3. Product Portfolio 239
12.9.4. Recent Developments 240
12.10. Zeus Scientific, Inc. 240
12.10.1. Company Overview 240
12.10.2. Zeus Scientific, Inc.; Company Snapshot 240
12.10.3. Product Portfolio 241
12.10.4. Recent Developments 242
12.11. Mbl International 243
12.11.1. Company Overview 243
12.11.2. Mbl International; Company Snapshot 243
12.11.3. Product Portfolio 244
12.11.4. Recent Developments 244
12.12. Medsource Ozone Biomedicals Pvt. Ltd 245
12.12.1. Company Overview 245
12.12.2. Medsource Ozone Biomedicals Pvt. Ltd; Company Snapshot 245
12.12.3. Product Portfolio 245
12.12.4. Recent Developments 245
12.13. Aesku Group Gmbh & Co. Kg 246
12.13.1. Company Overview 246
12.13.2. Aesku Group Gmbh & Co. Kg; Company Snapshot 246
12.13.3. Product Portfolio 247
12.13.4. Recent Developments 247
13. Related Reports 248